Katarina Wallentin

This profile gathers the share dealings of Katarina Wallentin in EQL Pharma AB. Between 29 November 2018 and 22 March 2019, the trades on record add up to 5 filings.

Purchases make up the whole of the open-market record (5 purchases, €17k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2019 to date brings 2 purchases and no sales.

Half of the purchases are above €1,761 and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 22 March 2019: an open-market purchase of €1,761, in EQL Pharma AB. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.